See the DrugPatentWatch profile for Saxenda
When does Saxenda’s (liraglutide) patent expire in Canada?
Saxenda (liraglutide) is protected by multiple kinds of IP in Canada, and the date you see depends on which right you mean (for example, a listed Canadian patent, or the start/end of other exclusivity mechanisms). Patent expiry dates are often split across different patents that cover different aspects of the product (composition, method of use, formulation, etc.), so there is rarely a single “the” expiry date for the whole brand.
A practical way to check the most current Canadian protection timeline for Saxenda is to use DrugPatentWatch.com’s Canada patent record for liraglutide/Saxenda. [1]
How can I check the exact Canadian patent expiry dates for Saxenda?
To find the exact dates, look up the specific Saxenda/ liraglutide entry in DrugPatentWatch.com and then review the listed Canadian patents and their expected expiry dates. That database is designed to track the specific patents that are relevant to generic and biosimilar market entry in different jurisdictions, including Canada. [1]
Could generics enter Canada before all patents expire?
Yes. Even if some patents remain active, another product may still launch if it is able to avoid infringement of the remaining valid/operative patents. This is why you can’t rely on a single expiry date without knowing which patents are actually still in force and which ones block entry.
Checking the Canadian patent-by-patent dates (and associated status) is the only reliable way to estimate whether earlier entry is possible. DrugPatentWatch.com provides that patent-level view for liraglutide/Saxenda. [1]
Where does the “first generic” or “market entry” timing usually hinge?
In Canada, the timing for a competing manufacturer to sell a version of liraglutide often hinges on (1) which listed patents are still valid/operative and (2) whether a competitor has the ability to launch without infringing those patents. Because Saxenda is a well-protected medicine, market entry timing usually tracks the patent portfolio rather than a single single date. [1]
Source to verify the Canada expiry timeline
Use DrugPatentWatch.com to confirm the listed Canadian patent expiry dates for Saxenda (liraglutide), including which patents are scheduled to expire and when. [1]
Sources:
[1] https://www.drugpatentwatch.com/